Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E29.22 EPS (ttm)1.90 Insider Own0.03% Shs Outstand2.88B Perf Week1.43%
Market Cap160.13B Forward P/E15.56 EPS next Y3.57 Insider Trans4.59% Shs Float2.87B Perf Month-7.91%
Income5.61B PEG5.34 EPS next Q0.88 Inst Own75.40% Short Float0.80% Perf Quarter-3.95%
Sales43.55B P/S3.68 EPS this Y-26.50% Inst Trans-0.23% Short Ratio2.46 Perf Half Y-2.08%
Book/sh16.58 P/B3.35 EPS next Y2.68% ROA5.40% Target Price63.30 Perf Year23.27%
Cash/sh4.64 P/C11.95 EPS next 5Y5.48% ROE11.50% 52W Range43.23 - 60.98 Perf YTD13.45%
Dividend1.76 P/FCF30.72 EPS past 5Y-16.50% ROI6.60% 52W High-8.97% Beta0.46
Dividend %3.17% Quick Ratio1.50 Sales past 5Y13.00% Gross Margin60.20% 52W Low28.41% ATR1.15
Employees77300 Current Ratio1.90 Sales Q/Q-0.70% Oper. Margin18.60% RSI (14)39.54 Volatility1.82% 1.92%
OptionableYes Debt/Eq0.48 EPS Q/Q126.70% Profit Margin12.90% Rel Volume1.37 Prev Close55.13
ShortableYes LT Debt/Eq0.38 EarningsOct 27 BMO Payout90.60% Avg Volume9.39M Price55.51
Recom2.50 SMA20-3.92% SMA50-5.54% SMA200-1.35% Volume12,901,718 Change0.69%
30-Apr-14Reiterated Argus Buy $62 → $66
11-Apr-14Reiterated MKM Partners Buy $64 → $70
05-Feb-14Reiterated Argus Buy $54 → $62
14-Jan-14Reiterated MKM Partners Buy $59 → $64
03-Jun-13Reiterated MKM Partners Buy $54 → $59
15-Apr-13Reiterated Barclays Overweight $45 → $60
04-Feb-13Reiterated MKM Partners Buy $51 → $52
04-Feb-13Reiterated Barclays Overweight $46 → $45
20-Nov-12Upgrade MKM Partners Neutral → Buy $47 → $51
17-Oct-12Reiterated MP Advisors Outperform $45 → $50
30-Jul-12Reiterated UBS Buy $45 → $50
13-Jul-12Upgrade MP Advisors Market Perform → Outperform $45
03-Feb-12Reiterated Barclays Capital Overweight $38 → $40
03-Feb-12Downgrade MKM Partners Buy → Neutral $42 → $40
29-Nov-11Initiated MKM Partners Buy $38
14-Sep-11Reiterated Barclays Capital Overweight $41 → $38
16-May-11Reiterated UBS Buy $40 → $42
04-Feb-11Reiterated UBS Buy $42 → $40
24-Jan-11Reiterated Deutsche Bank Buy $48 → $43
24-Jan-11Reiterated Barclays Capital Overweight $43 → $41
20-Oct-14 01:00PM  Dow Jones (DJIA) Today: Merck (MRK) Higher at TheStreet
08:00AM  US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteurs Investigational Pediatric Hexavalent Vaccine Business Wire
08:00AM  Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals PR Newswire
18-Oct-14 09:57AM  Ebola Outbreak Shows The Dark Side Of Mother Nature at Forbes
17-Oct-14 06:37PM  U.S. cattle industry grapples with quality versus quantity Reuters
02:41AM  Roche, Merck extend immunotherapy fight to breast cancer Reuters
16-Oct-14 11:49AM  Merck and Ranbaxy Settle Allegations of Overcharging Medicaid Programs at The Wall Street Journal
11:10AM  Will Actavis Win Competition For Allergan's Affection? Benzinga
15-Oct-14 05:09PM  MERCK & CO. INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:04PM  Merck unit to pay $31 mln to settle fraud claims by U.S. states Reuters
01:20PM  Cramer: The Bears on the Move -- and the Panic Is Palpable at TheStreet
08:00AM  Merck Announces Final Results of Tender Offers for Eight Series of Notes Business Wire
12:01AM  Repo Rules, Tipper Charged, Broken Windows: Compliance at Bloomberg
14-Oct-14 07:25PM  Ex-financial analyst facing insider trading charge AP
06:20PM  Merck Announces Pricing of Tender Offers for Eight Series of Notes Business Wire
04:52PM  Ex-Merck analyst faces insider trading charges on merger tips Reuters
12:00PM  Ex-Merck Analyst Charged With Telling Friend of Buyout at Bloomberg
10:48AM  Former Merck analyst faces insider trading charges on merger tips Reuters
13-Oct-14 04:33PM  IPO Calendar: Biotech Companies Lead List Of 7 IPOs at Investor's Business Daily
01:59PM  Alnylam Drug Scores Against Rare Nerve Disease at Investor's Business Daily
01:00PM  Dow Jones (DJIA) Today: Merck (MRK) Lower at TheStreet
08:07AM  5 Companies That Could Develop An Enterovirus Treatment Benzinga
10-Oct-14 05:17PM  New once-a-day pill for hepatitis C wins FDA OK AP
09-Oct-14 06:25PM  Cramer: Activists are picking on the wrong chiefs at CNBC
05:44PM  What's the Dollar Value of Online Patient Chatter? at BusinessWeek
02:00PM  Scientists find lung cancer can lie hidden for 20 years Reuters
09:00AM  Why companies like BAE and Bayer issued debt in US markets Market Realist
02:18AM  Glaxo Agrees to Take 25% Stake in Aspen Pharmacare Japanese Unit at Bloomberg
08-Oct-14 06:38PM  Merck to release hep C data Investor's Business Daily
05:20PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
04:01PM  The 4 Stocks That Dominated the Market 24/7 Wall St.
02:00PM  Stocks extend gains on FOMC minutes; Dow up 100 points at CNBC
01:36PM  Merck, Bristol, Arrowhead Prep Hepatitis Studies at Investor's Business Daily
11:13AM  Merck to Present New Data from Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-5172/MK-8742) at the 65th American Association for the Study of Liver Diseases Annual Meeting Business Wire
10:00AM  Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, E I Du Pont De Nemours & Company (DD) Lags at TheStreet
07-Oct-14 04:51PM  Ebola vaccine use likely to be confined, experts say at MarketWatch
11:13AM  Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo at Investor's Business Daily
06-Oct-14 01:36PM  New Issue- Merck & Co prices multi tranche deal Reuters
12:38PM  Merck & Co., Inc. -- Moody's rates Merck's new euro notes A2; stable outlook at Moody's
12:28PM  Merck Prices EUR 2.5 Billion Debt Offering Business Wire
11:41AM  Merck sale boosts Europe's corporate bond market at Financial Times
03:24AM  Merck Announces Proposed Public Debt Offering Business Wire
03:18AM  Merck Announces Tender Offers for Eight Series of Notes Business Wire
05-Oct-14 10:31PM  '60 Minutes' Just Attacked High Drug Prices. Here's What You Should Know. at Forbes
03-Oct-14 04:01PM  The 4 Stocks That Boosted the Market at 24/7 Wall St.
09:00AM  Merck Congratulates Ecuador as Second Country to Receive PAHO/WHO Verification of Elimination of River Blindness Business Wire
02-Oct-14 12:57PM  European stocks flop as ECBs Draghi talks stimulus at MarketWatch
08:44AM  MERCK & CO. INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exh EDGAR Online
03:20AM  [$$] Bayer Sells $7 Billion Bond at The Wall Street Journal
01-Oct-14 06:08PM  Cramer selloff plan: Surviving as stocks tumble at CNBC
06:03PM  Esperion shares rally on cholesterol drug study at MarketWatch
05:47PM  Esperion jumps on high-cholesterol drug data AP
04:05PM  Esperion drug succeeds in lowering LDL cholesterol -study Reuters
12:03PM  Bayer Said to Plan Bond Sale to Help Purchase Merck Unit at Bloomberg
11:57AM  [$$] Immuno-Oncology Agents Get Another Boost at Barrons.com
11:30AM  Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion Business Wire
30-Sep-14 12:02PM  J&J Buying Alios, Going Up Against Gilead at Investor's Business Daily
07:45AM  1 year later: Buy stocks booted from the Dow? Yahoo Finance
29-Sep-14 04:19PM  Indian Prime Minister courts U.S. CEOs at MarketWatch
02:16PM  Business events scheduled for Tuesday AP
01:31PM  Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader Benzinga
11:14AM  Cancer drug stocks on the move amid striking data at CNBC
09:00AM  Merck Partners with eSSENTIAL Accessibility to offer app for people with disabilities CNW Group
05:00AM  MSD Announces First Presentation of Early Data on the Investigational Use of Pembrolizumab in Patients with Advanced Bladder Cancer at ESMO 2014 Business Wire
05:00AM  Merck immunotherapy drug shows promise in bladder cancer Reuters
05:00AM  Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA┬« (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014 Business Wire
28-Sep-14 03:15AM  MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at ESMO 2014 Business Wire
03:15AM  Merck drug extends immune system fight to stomach cancer Reuters
03:15AM  Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA┬« (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014 Business Wire
26-Sep-14 05:08PM  Bristol immunotherapy gets 6-month U.S. FDA review for melanoma Reuters
12:58PM  FMHR Final Trade: MRK, NCR & more CNBC
12:58PM  [video] FMHR Final Trade: MRK, NCR & more at CNBC
12:00PM  Dow Jones (DJIA) Today: Merck (MRK) Lower at TheStreet
24-Sep-14 11:37PM  Top 100 Richest Indians: India's Pharma Sector Mints Billionaires at Forbes
05:29PM  Gilead's New HIV Drug Key To Long-Term Strategy at Investor's Business Daily
05:00PM  Merck to Hold Third-Quarter 2014 Sales and Earnings Conference Call on October 27 Business Wire
23-Sep-14 04:19PM  Stocks fall amid global concerns; small caps hit again at CNBC
12:52PM  Siemens U.S. Deal Hands Kaeser Second Win Over Ex-Boss at Bloomberg
08:00AM  Merck KGaA Records the Largest Acquisition in Their History at $17 Billion (Revised) Zacks
03:17AM  [video] German Companies Splurge on U.S. Deals at Bloomberg
01:35AM  [$$] Germany's Merck Buys New Tools to Aid Performance at The Wall Street Journal
22-Sep-14 06:01PM  Your first trade for Tuesday at CNBC
05:27PM  Stocks end lower: Nasdaq off more than 1% at USA TODAY
05:21PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
05:07PM  [video] Sigma-Aldrich Surges as Merck Makes Multibillion-Dollar Offer at TheStreet
02:57PM  [video] Rockefeller Family Divesting From Oil, and More at MarketWatch
02:25PM  Siemens to Merck Join German Rush to Make U.S. Deals at Bloomberg
01:43PM  Merck KGaA: Adrenalin shot at Financial Times
01:38PM  [$$] Germany's Merck Buys New Tools to Aid Performance at The Wall Street Journal
01:16PM  Why Jim Cramer Says Dresser-Rand (DRC), Sigma-Aldrich (SIAL), TRW (TRW) Acquisitions Are Important at TheStreet
10:17AM  Germany's Merck to buy Sigma-Aldrich for $17 billion Reuters
09:41AM  Merck KGaA to Buy Sigma-Aldrich for $17B to Add Chemicals Bloomberg
09:03AM  German Merck to buy St. Louis-based Sigma-Aldrich AP
06:44AM  Merck to buy US's Sigma-Aldrich for $17bn at Financial Times
06:31AM  Merck of Germany to Acquire Sigma-Aldrich for $17 Billion at New York Times
06:09AM  Merck KGaA to Buy Sigma-Aldrich for to Add Chemicals at Bloomberg
19-Sep-14 01:50PM  Is Merck KGaA on Track with its "Fit for 2018" Program? Zacks
11:30AM  Alibaba's IPO debut delayed two hours on 1st day of trading at USA TODAY
11:00AM  Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal PR Newswire
09:40AM  Dow 30 Stock Roundup: Boeing to Receive $4.2B Contract from NASA, Cisco to Acquire Metacloud Zacks
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEOOct 10Option Exercise34.2012,875440,272351,440Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOOct 10Sale59.739,895591,033341,545Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOSep 10Option Exercise34.2012,875440,272348,379Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOSep 10Sale60.489,814593,592338,565Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM